glp 1 agonist how does it work Mechanisms of action of GLP-1RA Frontiers | Exploring the multifaceted
Description
All studies to date on GLP-1 medications show nutritional consequences
Abdelaal M, le Roux CW, Docherty NG
Lancet 398 , 18111824 (2021) H.J.L
They are also called GLP 1 agonist
160,161 For example, HM15211, a triple agonist developed by Hanmi Pharmaceutical in South Korea that activates GLP-1R, GIPR and GCGR has entered early clinical trials for the treatment of obesity and non-alcoholic steatohepatitis (NASH)
